

Genzyme plight leaves patients uneasy

Ten-month-old Hannah Ostrea’s life hinges on an expensive drug made by just one company, Genzyme Corp. , based in Cambridge. (Full article: 1145 words)
This article is available in our archives:
Globe Subscribers
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
